跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KESIMPTA 20 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
KESIMPTA 20 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA
Approved
STANDARD
KESIMPTA 20 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA
Novartis Europharm Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
May 10, 2021
Approval ID
c6a8716a33585320
Company
Novartis Europharm Limited
Type
Standard
Approval Details
Approval Id
c6a8716a33585320
Drug Cima Aemps Name
KESIMPTA 20 mg SOLUCION INYECTABLE EN PLUMA PRECARGADA
Register Number
121532003
Holder Company Name
Novartis Europharm Limited
Marketing Company Name
Novartis Farmaceutica S.A.
Holder Company Detail Path
/organization/novartis-europharm-limited
Authorization Date
2021-05-10
Dosage Form
SOLUCIÓN INYECTABLE EN PLUMA PRECARGADA
Dose
20 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Novartis Europharm Limited
Company Detail Path
/organization/novartis-europharm-limited
Company Information
Pharmaceutical Company Name
NOVARTIS EUROPHARM LIMITED
Country Name
United Kingdom
City Name
camberley,country_gb
Address
200 Frimley Business Park
Active Ingredients
OFATUMUMAB
20 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
May 10, 2021
Approval ID
c6a8716a33585320
Type
Standard
Back to CIMA-AEMPS Approvals